WellTheory raised $5M in new funding led by Samsung Next, Opal Ventures, and Up2 Fund to expand into employer and health plan markets and enhance its AI-powered care infrastructure.
WellTheory raised $5M in new funding led by Samsung Next, Opal Ventures, and Up2 Fund to expand into employer and health plan markets and enhance its AI-powered care infrastructure.
05/22/25, 1:34 PM
Location
san franciscoMoney raised
$5 million
Industry
artificial intelligence
biotechnology
health care
Investors
Box Group, Ovo Fund, Accel, Up2 Fund, Opal Ventures, Samsung Next
WellTheory, based in San Francisco, CA, raised $5M to accelerate its expansion in the employer and health plan markets and improve its AI-powered care infrastructure. The funding includes participation from both new and existing investors. Led by CEO Ellen Rudolph, WellTheory offers a comprehensive virtual care platform for autoimmune diseases. Their latest AI tools support care teams by reducing prep time and enhancing care experience.
Company Info
Location
san francisco, california, united states
Additional Info
WellTheory is a San Francisco-based provider of a whole-person care platform for autoimmune disease. The company offers a virtual care platform that addresses the root cause of autoimmunity and treats the whole person, integrating an interdisciplinary team of autoimmune experts. Its proprietary AI assistant, Care Scribe, enhances the care experience by assisting providers with documentation and personalization of care plans. WellTheory aims to improve quality of life for patients while lowering healthcare costs.